How well does Hemlibra(Emicizumab) work?

Clinical trials demonstrated significant reduction in annualized bleeding rates.

Clinical Benefits

HEMLIBRA significantly reduced treated and spontaneous bleeding episodes in patients with and without factor VIII inhibitors. Most patients achieved zero bleeds, supporting its efficacy as a prophylactic treatment in hemophilia A.

Emicizumab(Hemlibra)
Routine prophylaxis to prevent or reduce bleeding episodes in patients with hemophilia A, with or without Factor VIII inhibitors.
RELATED ARTICLES
/ 0
0 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved